ADVANCING ANTIVIRAL DRUG DISCOVERY: INSIGHTS GAINED FROM COVID-19
;
Ensitrelvir, bemnifosbuvir, alisporivir (Debio-025), medicinal chemistry, Remdesivir (Gilead Sciences).Abstrak
The COVID-19 pandemic spurred unprecedented rapid and collaborative efforts in drug discovery across academia and industry, leading to the development, approval, and deployment of several therapeutics within just two years. This article highlights the collective experiences of pharmaceutical companies and academic collaborations actively engaged in SARS-CoV-2 antiviral research. Key stages of the small-molecule drug discovery process are discussed, including target selection, medicinal chemistry, antiviral assays, animal efficacy studies, and strategies to anticipate resistance. We emphasize the critical need for high-quality chemical probes targeting understudied viral proteins, which could serve as foundational tools for future drug discovery efforts. Given the relatively small size of viral proteomes, systematically developing a comprehensive set of chemical probes for proteins in viruses with pandemic potential represents a feasible and valuable challenge for the scientific community.
Iqtiboslar
Gibb, R., Franklinos, L. H. V., Redding, D. W. & Jones, K. E. Ecosystem perspectives are needed to manage zoonotic risks in a changing climate. Br. Med. J. 371, m3389 (2020).
Vidal, J. Destroyed habitat creates the perfect conditions for coronavirus to emerge. [Reprinted from Ensia] Scientific American https://www.scientificamerican.com/article/destroyed-habitat-creates-the-perfect-conditions-for-coronavirus-to-emerge/ (18 March 2020).
Messina, J. P. et al. The current and future global distribution and population at risk of dengue. Nat. Microbiol. 4, 1508–1515 (2019).
Goldin, I. & Mariathasan, M. The Butterfly Defect: How Globalization Creates Systemic Risks, and What to Do about It. Princeton Univ. Press (2015).
Chaudhuri, S., Symons, J. A. & Deval, J. Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond. Antiviral Res. 155, 76–88 (2018).
Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459–468 (2020).
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280.e8 (2020).
Collins, F. S. & Stoffels, P. Accelerating COVID-19 therapeutic interventions and vaccines (ACTIV): an unprecedented partnership for unprecedented times. JAMA 323, 2455–2457 (2020).
Musayeva, S. I. (2024). ADVANTAGES AND DISADVANTAGES OF INTERACTIVE METHODS INTRODUCING THE СLT (СOMMUNIСATIVE LANGUAGE TEACHING) APPROACH. World Scientific Research Journal, 32(1), 217-219.
Kumar, N. et al. Host-directed antiviral therapy. Clin. Microbiol. Rev. 33, e00168-19 (2020).
Wood, A. & Armour, D. In Progress in Medicinal Chemistry (eds King, F. D. & Lawton, G.) 239–271 (Elsevier, 2005).
